Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

ABSTRACT: Ongoing research into the application of nanotechnology for cancer treatment and diagnosis has demonstrated its advantages within contemporary oncology as well as its intrinsic limitations. The National Cancer Institute publishes the Cancer Nanotechnology Plan every 5 years since 2005. The most recent iteration helped codify the ongoing basic and translational efforts of the field and displayed its breadth with several evolving areas. From merely a technological perspective, this field has seen tremendous growth and success. However, an incomplete understanding of human cancer biology persists relative to the application of nanoscale materials within contemporary oncology. As such, this review presents several evolving areas in cancer nanotechnology in order to identify key clinical and bi

SUBMITTER: Hartshorn CM 

PROVIDER: S-EPMC6589353 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature